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Background: LVNC is a rare congenital disorder, described for the first time by Engberding in 1984. The suspected
diagnosis in thromboembolic, hemodynamic, or rhythm events requires both echocardiography and cardiovascular
magnetic resonance (CMR). Its therapeutic management is not yet well codified but akin to that proposed for dilated
cardiomyopathy.
Patients and design: This study included a retrospective, descriptive, and analytical cohort of 23 cases of cardiomy-
opathy with LVNC diagnosed in the Noninvasive Explorations Laboratory at the Military Hospital of Rabat,
Morocco, between January 2009 and October 2014. The echocardiographic criteria for LVNC include the absence
of any coexisting cardiac anomalies. The characteristic appearance of numerous excessively prominent trabecula-
tions and deep intertrabecular recesses and intertrabecular spaces filled by direct blood flow from the ventricular
cavity, as visualized on color Doppler imaging with noncompacted/compacted ratio > 2 according to Jenni criteria.
Twenty-three adults fulfilled the diagnostic criteria and were followed prospectively.
Results: At diagnosis, the mean age was 47  13 years with a male predominance at 65.2%. Of them, 56.5% had a
left bundle branch block and 21.7% were in atrial fibrillation. Left ventricular end-diastolic diameter was
67.7  6.6 mm and ejection fraction was at 27  8%. Apex and/or midventricular segments of both the inferior and
lateral wall were involved in more than 80% of patients with an average of 4.8 noncompacted segments. CMR
was performed in 12 patients and was decisive for the diagnosis. Major complications were heart failure in 31%
of patients, ventricular tachycardia in three patients, and thromboembolic events in one patient. Twenty eight point
six percent of patients started a long-term anticoagulant therapy. One patient underwent implantation of a double-eCCBY-
nd pre-
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2016;xxx:xxx–xxxroom pacemaker. Automated defibrillators were implanted in two patients. There were three deaths: one sudden
death and two end-stage heart failure.
Conclusion: LVNC should be looked for at any dilated cardiomyopathy particularly in young patients. It requires
a careful echocardiographic examination and sometimes CMR to confirm the diagnosis. It is characterized by severe
systolic and diastolic dysfunction that would provide poor prognosis.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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CMR Cardiac Magnetic Resonance
LVNC Left Ventricular Non Compaction
LV left ventricular
INR Index Normalized Ratio
LVEF left ventricular ejection fraction
NC/C non compacted/compacted
CRT Cardiac Resynchronization Therapy
VT ventricular tachycardia
ICD implantable cardioverter defibrillatorIntroduction
Noncompacted myocardium has been catego-rized as an unclassified cardiomyopathy by
the European Society of Cardiology in a published
report concerning definitions and classifications of
cardiomyopathies [1].
In patients with pulmonary atresia, regression of
the embryogenic sinusoids is impairedduringonto-
genesis by ventricular pressure overload that
results in deep recesses that communicate with
both the ventricular cavity and the coronary artery
system [2–4]. By contrast, left ventricular noncom-
paction (LVNC) is characterized by an embryogenic
hypothesis characterized by an altered structure of
themyocardial wall as a result of intrauterine arrest
of compaction of the myocardial fibers and
meshwork, an important process in myocardial
development in the absence of any coexisting con-
genital lesion [5,6]. There is continuity between
the LV cavity and the deep intratrabecular recesses
that are filledwith blood from the ventricular cavity
without evidence of communication to the epicar-
dial coronary artery system [7,8]. Since the original
description, therehavebeenonly a fewpublications
of case reports and small patient series predomi-
nantly describing a pediatric population [9–11].
Despite an increasingawareness and interest in this
anomaly, there is still little knowledge regarding
diagnostic criteria, symptoms, and prognosis of this
rare congenital disorder categorized as unclassified
cardiomyopathy [1]. This study was designed to
report clinical, echocardiographic, angiographic,
and rhythmic characteristics and long-term out-
comes to look for predictive factors of mortality in
the largest North African population of adults with
LVNC ever described in Morocco.Methods
Study population
From January 2009 to October 2014, 23 adults
(ageP 18 years, 15 men) fulfilled the diagnosticPlease cite this article in press as: Asfalou I. et al., Left ventricular noncom
dictors of mortality in adults through 23 cases, J Saudi Heart Assoc (2016),criteria of LVNC and their data were entered into
the database of our laboratory. Informed consent
was given by all patients that were recruited in
two ways: the first comprising patients hospital-
ized in the cardiology department at the intensive
care or the clinical units for heart failure or cardiac
rhythm disorder, or patients followed in consulta-
tion for LV dysfunction, arrhythmia, or during an
exploration of syncope, chest pain, dyspnea, or
palpitations.
Data acquisition
Clinical assessment included a detailed medical
historyusing standardizedquestionnaires.Medical
records were reviewed. Sudden death was defined
as occurring within 1 hour of the patient’s usual
state of health or as an unwitnessed death during
sleep [12]. All patients had a 12-lead resting electro-
cardiogram (ECG), chest radiography, and a com-
plete two-dimensional Doppler echocardiographic
exam as described below. Additionally, a 24-hour
Holter monitoring was performed in 19 patients.
Nonsustained ventricular tachycardia was defined
as ventricular tachycardia of more than three pre-
matureventricular contractions lastingup to 30 sec-
onds. A ventricular run of more than 30 seconds
was defined as sustained ventricular tachycardia.
Instrumental echocardiography
A transthoracic echocardiogram was performed
with Vivid 7 or Vivid E9 (GE Vingmed Ultrasound
AS, Horten, Norway). Recorded loops werepaction—A rare form of cardiomyopathy: Revelation modes and pre-
http://dx.doi.org/10.1016/j.jsha.2016.02.004
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Figure 1. Clinic symptoms. TIA = transient ischemic attack.
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Figure 2. Electric data. AF = atrial fibrillation; LBBB = left bundle branch block; SVT = supraventricular tachycardia.
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LEFT VENTRICULAR NONCOMPACTIONvisualized and analyzed by at least two operators.
The echocardiographic diagnostic was retained as
proposed by Jenni criteria.
A complete two-dimensional and Doppler
echocardiographic examination was performed
in all symptomatic patients and in a family screen-
ing context performed in almost all retained
patients except constraints, according to the
recommendations of the American Society of
Echocardiography including two-dimensional
guided M-mode measurements [13]. Only one
case was retained in the family context. LV
ejection fraction (LVEF) was calculated using the
biplane area SIMPSON method.
The study also considered the number of non-
compacted segments and measurement of the
noncompacted area/compacted area ratio (NC/C
ratio) and associated anomalies and calculated
the blood pressure pulmonary systolic.
Cardiovascular magnetic resonance
Cardiovascular magnetic resonance (CMR) was
performed in 12 patients with a doubt about the
diagnosis at the echocardiography.
Coronary angiography
This was realized for 18 patients.
Statistical analysis
Statistical data were analyzed on Excel then IBM
SPSS 20 statistics (IBM Inc., Armonk, NY, USA)Please cite this article in press as: Asfalou I. et al., Left ventricular noncom
dictors of mortality in adults through 23 cases, J Saudi Heart Assoc (2016),and expressed as mean or median  standard
deviation.Results
Epidemiology data
The mean age was 47  13 years with a male
predominance at 65.2% and a sex ratio at 1.8. Four-
teen patients (60.8%) had no cardiovascular risk
factor. A family history of sudden death was found
in one patient.
Clinical data
Clinical characteristics of the study population
are presented in Fig. 1. The age range at the time
of diagnosis was wide (19–72 years). Reasons for
referral were: heart failure in 51%, pain chest in
9%, 4% for both palpitations and transient
ischemic attack, and syncopal event in 13%. One
patient was referred in the context of a family sur-
vey; a sister of one patient was screened because
of the familial occurrence risk and was diagnosed
to have LVNC. Familial occurrence of LVNC was
present in one case.
Fifteen patients were followed for another diag-
nosis within an average of 2.88 years (from
1 month to 21 years) before the LVNC was diag-
nosed. From the beginning, 91.3% of patients were
symptomatic—the diagnosis was fortuitously dis-
covered in only two asymptomatic patients. The
ECGwas abnormal in all of patients. Fifty six point
five percent of patients had left bundle branchpaction—A rare form of cardiomyopathy: Revelation modes and pre-
http://dx.doi.org/10.1016/j.jsha.2016.02.004
Anterolateral 
Inferolateral
Apex
Boom wall
Inferoseptal
Anterior
Anteroseptal
18.75%
12.50%
6.25%
86%
62%
62%
57%
Figure 3. Various noncompacted cardiac walls (according to the 17 segments model).
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Table 1. Echocardiographic data.
Measurements (AVRG  ET) Minimum Maximum
LVEDD 67.6  6.6 58 83
LVEF 27  8 13 41
NC segments 4.8  0.2 1 10
NC/C ratio 2.12  0.14 2 2.4
AVRG = average; ET = endothelin; LVEDD = left ventricular end-diastolic diameter; LVEF = left ventricular ejection fraction; NC = noncompacted;
NC/C = noncompacted/compacted.
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and premature ventricular contractions in 13%
patients (Fig. 2). No neuromuscular disorders or
any other comorbidities were found.Echocardiographic data
Echocardiographic findings at the first presenta-
tion are summarized in Table 1. The LV end-
diastolic diameter was 67.7  6.6 mm (58; 83) and
the ejection fraction was at 27  8% (13; 41). Apex
and/or midventricular segments of both the infe-
rior and lateral wall were involved in > 80% of
patients with an average of 4.8 noncompacted
segments (1; 10).
Parts that were of particular concern (according
to the 17 segments model) were the anterolateral
wall (86%), infero-lateral wall (62%), the apical
wall (62%), and the inferior wall (57%). NC/C ratio
was 2.12  0.14 (2; 2.4; Fig. 3).
Global LV hypokinesia was noted in 69.6% of
patients and segmental disorder kinetics in
30.4%. There was a low flow in 17 patients and a
restrictive mitral flow in 14 patients. The left ven-
tricle was the site of a spontaneous contrast with-
out visible thrombus in two patients.
Pulmonary arterial hypertension was found in
11 cases (47.8%) with an average of the pulmonary
arterial systolic pressure at 49 mmHg. Among the
major associated abnormalities, there was an
ostium secundum atrial septal defect in two
patients without hemodynamic repercussion,Please cite this article in press as: Asfalou I. et al., Left ventricular noncom
dictors of mortality in adults through 23 cases, J Saudi Heart Assoc (2016),tricuspid regurgitation in 18 patients, and minimal
to medium mitral regurgitation in all patients. The
right ventricular was normal for all patients.
CMR data
Echocardiography was performed for all the
patients. It was decisive in 11 cases, but the
use of CMR was needed to confirm and retain
the diagnosis in 12 patients, taking as diagnosis
the threshold of 2.3 in diastole for the thickness
NC/C ratio [14].
Coronary was normal in 15 of the 18 patients
who had undergone coronary angiography, two
had a double vessel lesion and one had a simple
vessel lesion.
The 24-hour Holter ECG was performed in 18
patients. It showed a monomorphic ventricular
extrasystole in seven cases, nonsustained ventric-
ular tachycardia in three, one accelerated idioven-
tricular rhythm, one paroxysmal atrial fibrillation
passage, and it was normal in six patients (Fig. 4).
An electrophysiological study was performed in
a patient with a history of sudden death in his
family and who had a repeated syncope. It con-
cluded at an atrioventricular conduction disorder
justifying the final pacing.
Treatment
During the study, the acenocoumarol (interna-
tional normalized ratio 2–3) was given to 28.6% of
patients with LV dysfunction (LVEF < 30%) orpaction—A rare form of cardiomyopathy: Revelation modes and pre-
http://dx.doi.org/10.1016/j.jsha.2016.02.004
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Figure 4. Holter electrocardiogram data. AIVR = accelerated idioventricular rhythm; NSVT = nonsustained ventricular tachycardia; VES =
ventricular extrasystole.
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LEFT VENTRICULAR NONCOMPACTIONatrial fibrillation or a history of thromboembolic
episodes. The treatment for heart failure and
LV dysfunction was based on current clinical
guidelines [15].
A biventricular cardioverter defibrillator was
implanted in two patients with a history of
sustained ventricular tachycardia. Both patients
benefited from the resynchronization therapy.
Biventricular pacing systems were implanted in
two additional patients with heart failure despite
optimal medical treatment.
No patient underwent cardiac transplantation
because it is currently an undeveloped therapy
in Morocco.
Evolution and mortality
Forty-three point five percent of heart failure
patients required hospital admission and 56.5%
were stabilized with medications remaining in
Class II New York Heart Association (NYHA).
Two died because of end-stage heart failure.
Thromboembolic events were represented by an
episode of transient ischemic attack observed in
one patient.
Three patients sustained a reduced ventricular
tachycardia. An implantable cardioverter defibril-Table 2. Statistics table.
Parameters p in univariate
Age 0.8
Male sex 0.005
Iterative episodes of HF 0.03
Embolic events 0.09
NYHA Class III/IV 0.02
Chronic AF 0.05
LBBB 0.03
SVT 0.02
LVEDD >65 mm 0.03
LVEF <30% 0.03
NC segments 0.03
NC/C ratio 0.02
AF = atrial fibrillation; HF = heart failure; LBBB = left b
diastolic diameter; LVEF = left ventricular ejection
pacted/compacted; NYHA = New York Heart Associati
Please cite this article in press as: Asfalou I. et al., Left ventricular noncom
dictors of mortality in adults through 23 cases, J Saudi Heart Assoc (2016),lator was to be implanted in two patients but
one of those patients died (sudden death) from
recurrent and refractory sustained ventricular
tachycardia before the implanted cardioverter
defibrillator.
In addition to the three deaths described above,
recently there was a fourth death due to an extrac-
ardiac cause which was Lyell’s syndrome.
No patients underwent autopsy during the
study.
Characteristics of survivors and nonsurvivors
All nonsurvivors were men (p < 0.001) with
LVEF < 30% (p < 0.005). The LV end-diastolic
diameter was significantly larger for male nonsur-
vivors (70  9 mm) and not as much for survivors
(61  12 mm; p < 0.005). NYHA Class III/IV (63%
vs. 11%; p < 0.005), chronic atrial fibrillation (50%
vs. 39%; p < 0.05), bundle branch block (75% vs.
39%; p < 0.045), total number of noncompacted
segments more than five (76% vs. 23%; p < 0.001),
and NC/C ratio more than 2.2 (89% vs. 14%;
p < 0.001; Table 2).
There was no significant difference between
survivors and nonsurvivors regarding age at
diagnosis, heart failure requiring hospitalanalysis p in multivariate analysis
–
<0.001
0.08
–
<0.005
0.05
0.045
0.1
<0.005
<0.005
<0.001
<0.001
undle branch block; LVEDD = left ventricular end
fraction; NC = noncompacted; NC/C = noncom-
on; SVT = supraventricular tachycardia.
paction—A rare form of cardiomyopathy: Revelation modes and pre-
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events and sustained ventricular tachycardia.
The period of clinical, electrical, and echocardio-
graphic follow-up during the study was set at
2 years. For some patients (collected at the end
of the study) monitoring is still ongoing.
During follow-up, the morphology and topogra-
phy of LVNC did not change, but we have noted a
worsening of the LV dysfunction in some patients.Discussion
We report the largest Moroccan study of adult
patients followed for LVNC, including the first for-
mal analysis of prognosis factors. Unlike the previ-
ously reported cohorts recruiting inpatients or
outpatients and which are generally focused on
patients with a symptomatic diagnosis, patients
in the present study are identified by an echocar-
diographic examination recruiting also nonsymp-
tomatic patients. Our data indicate that the
presentation spectrum of LVNC can be wider than
what was previously thought. Early reports about
the disease generally show dramatic cases,
whereas subsequent studies broaden progres-
sively the vision of the affected population, extend-
ing it to patients with less and less severe disease
[16]. The present study confirms and extends this
revised vision and provides first outcomes analysis
from a single referral center in Morocco.
The noncompaction of the left ventricle can be
isolated or associated to other congenital malfor-
mations (Ebstein anomaly, complex cyanotic heart
disease, etc.). Familial forms are not rare; about
25% of asymptomatic relatives have criteria for
LVNC [17]. Eight percent of patients in the French
registry reported by Habib et al. [18] were
detected as part of a family survey. A number of
genes involved have been identified.
A genetic study should be performed in our
study in order to support the embryogenic
hypothesis and rule out some particular pheno-
typic characteristics of LVNC which are identified
in cases including sickle cell anemia and athletes.
Athletes have trabeculations that do not reach 2:1
ratio for noncompacted and compacted layers. In
some patients with myocarditis or pregnancy the
criteria for LVNC are reached, but the trabecula-
tions regress after some time. Therefore the
embryogenic hypothesis is still controversial [19,20].
Classification and epidemiology
In 1996, the LVNC was mentioned by the World
Health Organization as an unclassified cardiomy-
opathy. Since 2006, it has been considered by thePlease cite this article in press as: Asfalou I. et al., Left ventricular noncom
dictors of mortality in adults through 23 cases, J Saudi Heart Assoc (2016),American Heart Association as a distinct genetic
cardiomyopathy [21]. However, for the European
Society of Cardiology, the last classification in
2008 still considers it as an unclassified cardiomy-
opathy. This highlights the nosological uncer-
tainty that persists about this entity [22].
It is caused by an abnormality of the embryoge-
nesis of the endocardium and myocardium in
utero, resulting in prominent ventricular trabecu-
lae with deep intertrabecular recesses [21]. And
although it is a congenital abnormality, the diag-
nosis is often established at the onset of complica-
tions at adulthood, as in the case of our center
which mainly receives a military active population
which explains the young age of our series of
patients.
Prevalence is still poorly known. In the rare
echocardiographic series that involve this disease
in adults, the reported prevalence varies from
0.01% to 0.27% [23]. At presentation, the most
common reasons for referral are heart failure
and uncertain echocardiographic findings.
Clinical presentation
All the major diagnostic pathways commonly
encountered in clinical practice were represented
in our series of patients. At presentation, the most
common reason for referral was heart failure at
51%. Although the fact that the embolic events
were a frequent complication in the initial publi-
cations, they were the reason for referral of just
one patient. This is explained by the early intro-
duction of anticoagulants.
Diagnosis
Diagnosis was delayed in most patients with a
delay time range from 1 month to 21 years in our
series. Echocardiography is the basic diagnostic
tool, but the criteria are not well established.
There are currently three echocardiographic
definitions: Chin is based on the calculation of
an X/Y ratio between the depth of intertrabecular
recesses relative to wall thickness, but end-
diastolic differentiation between noncompacted
and compacted myocardium was often difficult
[7]. Therefore, we proposed to identify our
patients by the criteria of Jenni et al. [6] which is
the most used criteria because they are best suited
for the measurement of NC/C ratioP2 at the end-
systolic in the left parasternal incidence short axe.
Finally, the criteria by Stöllberger et al. [24] for the
detection of more than three visible trabeculae on
the same cutting plane.
All patients of the cohort have dilated left
ventricles and systolic dysfunction. This can bepaction—A rare form of cardiomyopathy: Revelation modes and pre-
http://dx.doi.org/10.1016/j.jsha.2016.02.004
Figure 6. Short axis cine magnetic resonance imaging sequence
showing noncompacted lateral wall.
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left ventricular wall, with noncompacted/compacted ratio at 2.2.
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were seen at symptomatic stage (Fig. 5).
The echocardiographic diagnosis of this pathol-
ogy remains difficult, particularly because of the
essentially apical localization abnormalities (62%
in our series). This explains the delay between
the first echocardiographic examination and the
diagnosis. The LV systolic function is generally
more altered when the amount of noncompacted
myocardium is important.
However, it is not unusual to see perfectly nor-
mal ejection fractions in patients with LVNC
(16% of 105 patients included in the French reg-
istry) [18]. Indeed, the correlation study between
LVEF and the number of noncompacted segments
was performed objectifying a correlation ratio at
0.18 (low correlation). Studies using speckle track-
ing show early achievement of systolic function
even when the LVEF is preserved [25].
Two-dimensional strain also allows to
distinguish the noncompaction of the LV and
dilated cardiomyopathy, myocarditis, peripartal
cardiomyopathy, or hearts of athletes showing aPlease cite this article in press as: Asfalou I. et al., Left ventricular noncom
dictors of mortality in adults through 23 cases, J Saudi Heart Assoc (2016),relative preservation of the basal longitudinal
deformation with respect to the apex [26,27].
The CMR presents a number of advantages. It
provides high resolution images stamped in apical
regions. Petersen et al [14] proposed a diagnosis
threshold of thicknesses NC/CP 2.3 in diastole.
Indeed, CMR was performed in 12 patients in
our series and was decisive in retaining the diag-
nosis. The study with gadolinium shows that the
importance of delayed enhancement is correlated
with the severity of clinical signs and LV dysfunc-
tion [28] (Fig. 6).
Management
There are currently no specific treatment
recommendations for noncompaction of the left
ventricle. Symptomatic patients with LV dysfunc-
tion should receive the usual treatment of heart
failure. Careful rythmological monitoring should
be performed (Holter, stress test). The decision
of a defibrillator or resynchronization is based
on the usual recommendations. The introduction
of a systematic anticoagulation is controversial.
Because of the frequent family forms and the
theoretical risk of transmission of 50% in
autosomal recessive mutation cases, a systematic
screening for first-degree relatives should be
implemented and allows an earlier detection of
asymptomatic patients [24].
Prognosis
The largest current series are still relatively
small and do not allow for an accurate assessment
of prognosis of this disease. The reported mortal-
ity in the original series is high, ranging from 35%
to 47% over 42–72 months of follow-up periods,
but it may have been overestimated in the French
cohort: 11% of patients die during the follow-up
(27.6 months). A French study is currently
underway to determine the prognostic factors of
this disease compared with a population of classic
dilated cardiomyopathy.
In our cohort, prognostic factors were identified
as mortality predictors. Male sex, the LV
end-diastolic diameter reached 70  9 mm with
LVEF < 30% for nonsurvivors. NYHA Class
III/IV, chronic atrial fibrillation, left bundle branch
block, total number of noncompacted segments
more than five, and NC/C ratio more than 2.2
were the mortality factors in our series.Conclusion
This study indicates that LVNC can be
associated with a broad spectrum of clinical andpaction—A rare form of cardiomyopathy: Revelation modes and pre-
http://dx.doi.org/10.1016/j.jsha.2016.02.004
FU
LL LEN
G
TH
 A
RTIC
LE
8 ASFALOU ET AL
LEFT VENTRICULAR NONCOMPACTION
J Saudi Heart Assoc
2016;xxx:xxx–xxxpathophysiological findings and strengthens the
concept that the overall natural history and prog-
nosis of LVNC may be better than previously
thought. In particular, the diagnostic pathway
may be an important element of clinical evalua-
tion, with incidental and familial discovery of
LVNC being associated with a high probability
of a stable course for several years.
Conversely, male patients who have symptoms
of heart failure, LV end-diastolic diameter at
65 mm, ejection fraction at 30%, chronic atrial
fibrillation, left bundle branch block, total number
of noncompacted segments more than five, and
NC/C ratio more than 2.2 have an unstable clinical
course and a more severe prognosis.
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